Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Journal Syifa Sciences and Clinical Research (JSSCR)
Muhammad Akib Yuswar
Departemen Teknologi Farmasi, Fakultas Kedokteran, Universitas Tanjungpura, Jl. Prof. Dr. H. Handari Nawawi Kota Pontianak 78124, Indonesia
Chemistry Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Kualitas Hidup Pasien Diabetes Melitus Tipe 2 Berdasarkan Terapi Antidiabetik Aulia Dwi Rahmadani; Nera Umilia Purwanti; Muhammad Akib Yuswar
Journal Syifa Sciences and Clinical Research Vol 4, No 2 (2022): Volume 4 Edisi 2 2022
Publisher : State University of Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37311/jsscr.v4i2.14400

Abstract

Diabetes Mellitus (DM) is a metabolic disease characterized by hyperglycemia. Ninety percent of DM cases are type 2 DM. DM patients often receive effective treatment but have not been able to control glucose levels, this causes the quality of life of DM patients to decrease. This study aims to assess the quality of life of type 2 DM patients based on antidiabetic therapy used at the Siantan Hilir Health Center, Pontianak City in December 2021-January 2022. The research method used was observational with a cross-sectional design. Data was collected using purposive sampling technique and 30 patients met the inclusion criteria. The research data was obtained using the Diabetes Quality of Life Clinical Trial Questionnaire (DQLCTQ). The results of the questionnaire will be converted into numbers to get a score which will be processed into the average for each domain and the total value of quality of life. Quality of life is said to be low if the value is 62.2 which is obtained from the average total value of quality of life. More patients received monotherapy (62.69%) than combination therapy (37.31%). The most widely used type of therapy was metformin (52.24%). The quality of life of patients with type 2 DM with monotherapy is higher than the quality of life of patients with combination therapy.
Co-Authors Aulia Dwi Rahmadani Nera Umilia Purwanti, Nera Umilia